Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer.
Br J Cancer
; 120(3): 279-285, 2019 02.
Article
in En
| MEDLINE
| ID: mdl-30655615
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Phthalazines
/
Piperazines
/
Cyclophosphamide
/
Triple Negative Breast Neoplasms
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: